LUXEMBOURG--(BUSINESS WIRE)--Advanced Biological Laboratories (ABL) S.A. today announced that it has granted Abbott non-exclusive rights to market ABL’s software suite for HIV genotyping data analysis. Abbott will utilize its expertise in infectious disease diagnostics to offer ABL products for HIV genotyping, and facilitate access to the newest and up-to-date analysis of HIV genotyping to its customers in the United States.
“The USA is the largest single HIV genotyping market in the world, used in diagnostics and clinical trials” Dr. Chalom Sayada, MD, PhD, Chief Executive Officer at ABL said. “Our technology is a great addition to Abbott’s existing portfolio of HIV sequencing products, with real potential to address the important and growing need for precision and personalized medicine in real time, with all the required updates and upgrades.” This agreement in the USA is a strong strategic and commercial fit for ABL, reinforcing both our focus to develop synergies with established major industrial partners in clinical genotyping as a core business area, and expand the presence and use of ABL’s products the US market as one of ABL’s key growth drivers.”
About Advanced Biological Laboratories (ABL) S.A.:
Advanced Biological Laboratories (ABL), S.A., is a Medical Data Technology company founded in 2000 as a spin-off from CRP-Santé Luxembourg. ABL took control of TherapyEdge, Inc. in 2004 and in 2013 acquired the rights to all viral hepatitis B & C related assets from EVIVAR MEDICAL, respectively. ABL has a comprehensive suite of healthcare management products, including TherapyEdge®, ViroScore®, SeqHepB, DeepChek®, VisibleChek®, HepatiC™ and the DPM which are used for data and patient management, monitoring and personalized reporting applications. In 2012, some of ABL’s products also received CE-marking for IVD use. ABL’s products, ViroScore® Suite and DeepChek®, are for research use only in the United States, and the upcoming data processing module is an FDA registered class I medical device. ABL’s products offer infectious disease clinicians and virology laboratories optimal and efficient IT solutions, for sequencing, clinical genotyping, and drug resistance analysis, including powerful fully integrated databases and analysis systems combining standard and high-throughput Next Generation Sequencing data.
Contacts
ABL
Dr. Chalom Sayada, Tel: +352 2638 8921
Help employers find you! Check out all the jobs and post your resume.
